These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34052239)

  • 1. Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19).
    Pallotto C; Blanc P; Esperti S; Suardi LR; Gabbuti A; Vichi F; Mecocci L; Esposti AD; Pierotti P; Attala L; Salomoni E; Baragli F; Francisci D; Pietro MAD
    J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 34052239
    [No Abstract]   [Full Text] [Related]  

  • 2. Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature.
    Chow EJ; Maust B; Kazmier KM; Stokes C
    J Pediatric Infect Dis Soc; 2021 Oct; 10(9):926-929. PubMed ID: 34173663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019-The pilot study.
    Bistrovic P; Lucijanic M
    J Med Virol; 2021 Oct; 93(10):5724-5725. PubMed ID: 34232520
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19).
    Pallotto C; Suardi LR; Gabbuti A; Esperti S; Mecocci L; Blanc P
    J Med Virol; 2021 May; 93(5):2631-2634. PubMed ID: 33620107
    [No Abstract]   [Full Text] [Related]  

  • 5. Sinus Bradycardia in Children Treated With Remdesivir for COVID-19.
    Eleftheriou I; Liaska M; Krepis P; Dasoula F; Dimopoulou D; Spyridis N; Tsolia M
    Pediatr Infect Dis J; 2021 Sep; 40(9):e356. PubMed ID: 34285169
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe sinus bradycardia associated with remdesivir in a child with severe SARS-COV-2 infection-reply.
    Mendez-Echevarria A; Sándor-Bajusz KA; Calvo C
    Eur J Pediatr; 2021 May; 180(5):1629-1630. PubMed ID: 33464367
    [No Abstract]   [Full Text] [Related]  

  • 7. Remdesivir therapy associated with Bradycardia in SARS-CoV2.
    Kumar S; Arcuri C; Chaudhuri S; Gupta R; Aseri M; Barve P; Shah S
    Clin Cardiol; 2021 Sep; 44(9):1190-1191. PubMed ID: 34322890
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe sinus bradycardia associated with Remdesivir in a child with severe SARS-CoV-2 infection.
    Sanchez-Codez MI; Rodriguez-Gonzalez M; Gutierrez-Rosa I
    Eur J Pediatr; 2021 May; 180(5):1627. PubMed ID: 33483798
    [No Abstract]   [Full Text] [Related]  

  • 9. Remdesivir, Sinus Bradycardia and Therapeutic Drug Monitoring in Children With Severe COVID-19.
    Rau C; Apostolidou S; Singer D; Avataneo V; Kobbe R
    Pediatr Infect Dis J; 2021 Dec; 40(12):e528-e529. PubMed ID: 34591799
    [No Abstract]   [Full Text] [Related]  

  • 10. Remdesivir-associated bradycardia.
    Ching PR; Lee C
    BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34479903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man.
    Day LB; Abdel-Qadir H; Fralick M
    CMAJ; 2021 Apr; 193(17):E612-E615. PubMed ID: 33903133
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical Characteristics and Implications of Bradycardia in COVID-19 Patients Treated with Remdesivir: A Single-Center Retrospective Cohort Study.
    Schreiber A; Bauzon JS; Batra K; Mohammed S; Lee K; Houshmand N; Pham U; Cosme C; Inciong K; Al-Taweel O; Nasser K; Rana J; Sossou C; Go A; Hawwass D; Diep J; Ahsan CH
    Clin Drug Investig; 2022 Sep; 42(9):763-774. PubMed ID: 35978159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.
    Attena E; Albani S; Maraolo AE; Mollica M; De Rosa A; Pisapia R; Fiorentino G; Parrella R; Severino S; Russo V
    Circ Arrhythm Electrophysiol; 2021 Jul; 14(7):e009811. PubMed ID: 34182791
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of adverse events associated with remdesivir use for coronavirus disease 2019 using real-world data.
    Singh A; Kamath A
    Expert Opin Drug Saf; 2021 Dec; 20(12):1559-1564. PubMed ID: 34328807
    [No Abstract]   [Full Text] [Related]  

  • 15. Remdesivir-associated bradycardia might be a sign of good prognosis in COVID-19 patients.
    Lucijanic M; Bistrovic P
    Clin Microbiol Infect; 2022 Apr; 28(4):619. PubMed ID: 34999175
    [No Abstract]   [Full Text] [Related]  

  • 16. The Multidimensional Challenge of Treating Coronavirus Disease 2019 (COVID-19): Remdesivir Is a Foot in the Door.
    Gandhi RT
    Clin Infect Dis; 2021 Dec; 73(11):e4175-e4178. PubMed ID: 32735655
    [No Abstract]   [Full Text] [Related]  

  • 17. Bradycardia during remdesivir treatment might be associated with improved survival in patients with COVID-19: a retrospective cohort study on 473 patients from a tertiary centre.
    Bistrovic P; Manola S; Lucijanic M
    Postgrad Med J; 2022 Jul; 98(1161):501-502. PubMed ID: 34876485
    [No Abstract]   [Full Text] [Related]  

  • 18. [Remdesivir for patients with COVID-19].
    Augustin M; Hallek M; Nitschmann S
    Internist (Berl); 2020 Aug; 61(8):869-872. PubMed ID: 32572516
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of Remdesivir for COVID-19.
    Zhang H; Chen J; Wang X; Chen B
    Discov Med; 2021; 31(163):57-60. PubMed ID: 34965372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir.
    Camprubí D; Gaya A; Marcos MA; Martí-Soler H; Soriano A; Mosquera MDM; Oliver A; Santos M; Muñoz J; García-Vidal C
    Int J Infect Dis; 2021 Mar; 104():379-381. PubMed ID: 33359065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.